2-[4-(2-氨乙基)苯氧基]乙酸 | 55458-77-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-[4-(2-氨乙基)苯氧基]乙酸
• 英文名称: 4-(2-aminoethyl)-phenoxyacetic acid
• 英文别名: 4-(2-aminoethyl)phenoxyacetic acid；4-(2-Aminoethyl)-phenoxyessigsaeure；2-[4-(2-Azaniumylethyl)phenoxy]acetate
• CAS: 55458-77-0
• 化学式: C₁₀H₁₃NO₃
• mdl: MFCD08448865
• 分子量: 195.218
• InChiKey: DGPWASIVWNADCJ-UHFFFAOYSA-N

物化性质

• 沸点：
  365.4±22.0 °C(Predicted)
• 密度：
  1.212±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.5
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-[4-(2-氨乙基)苯氧基]乙酸 生成 4-(2-allyloxycarbonylaminoethyl)-phenoxyacetic acid
  参考文献：
  名称：

  Bicyclic beta-lactam carboxylic acids

  摘要：

  公式为##STR1##的化合物，其中R.sub.1是被羟基或保护羟基取代的低烷基，R.sub.2代表羧基或功能修饰的羧基，R.sub.3是氢、氨基、单取代或双取代氨基、氨基甲酰、羟基、保护羟基、羟基甲酰氧基、低烷氧基、卤素、低烷酰基、磺酰氨基或杂环硫基，R.sub.4和R.sub.5中的每一个，独立于另一个，代表氢、低烷基、羟基、保护羟基、低烷氧基、卤素、氨基、保护氨基、低烷酰氨基或氨基甲酰，或者R.sub.4和R.sub.5一起代表亚甲二氧基，Y代表--O--、--S--或--NR.sub.6 --的式团，R.sub.6是氢或低烷基，A.sub.1代表低烷基或未取代或取代的苯基，A.sub.2代表直接键或低烷基，以及这类化合物的盐，具有抗菌活性。公式I的化合物是通过已知的方法制造的。

  公开号：

  US04965260A1

文献信息

• C-terminal modified oxamyl dipeptides as inhibitors of the ICE-ced-3 family of cysteine proteases
  申请人：——

  公开号：US20020042376A1

  公开（公告）日：2002-04-11

  This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

  这项发明涉及新型的oxamyl二肽ICE/ced-3家族抑制剂化合物。该发明还涉及含有这些化合物的药物组合物，以及在治疗患有炎症性、自身免疫和神经退行性疾病的患者中使用这些组合物，用于预防缺血性损伤，并用于保存即将进行移植手术的器官。
• (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
  申请人：Idun Pharmaceuticals, Inc.

  公开号：US20030232788A1

  公开（公告）日：2003-12-18

  This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

  这项发明涉及新型（取代）酰基二肽酶ICE/ced-3家族抑制剂化合物。该发明还涉及含有这些化合物的药物组合物，以及将这些组合物用于治疗患有炎症、自身免疫和神经退行性疾病的患者，预防缺血性损伤，并保护即将进行移植手术的器官。
• Imidazole compounds, processes for their preparation, pharmaceuticals
  申请人：Hoechst Aktiengesellschaft

  公开号：US05232922A1

  公开（公告）日：1993-08-03

  Imidazole compounds of the formula I ##STR1## in which R.sup.1 =alkyl, R.sup.2 and R.sup.3 =H, halogen or alkyl, X=OH or an amide radical having certain substituents, processes for their preparation and pharmaceuticals based on these compounds, in particular for the prophylaxis and treatment of circulatory disturbances, especially of disturbances of the microcirculation and of the disorders resulting therefrom, and some novel intermediates for the preparation of the compounds of the formula I, which are 1-methyl-, 1,2-dimethyl- and 1-ethyl-4-imidazolesulfonyl chloride.

  咪唑化合物的结构式 I ##STR1## 中 R.sup.1 = 烷基，R.sup.2 和 R.sup.3 = H、卤素或烷基，X = OH 或具有特定取代基的酰胺基团，其制备方法及基于这些化合物的药物，特别用于预防和治疗循环障碍，尤其是微循环障碍及由此产生的疾病，以及用于制备结构式 I 化合物的一些新型中间体，其中包括 1-甲基、1,2-二甲基和 1-乙基-4-咪唑磺酰氯。
• Phenoxyalkylcarboxylic acid compounds and thrombocyte-aggregation
  申请人：Boehringer Mannheim GmbH

  公开号：US04258058A1

  公开（公告）日：1981-03-24

  Phenoxyalkylcarboxylic acid compounds of the formula ##STR1## wherein R is hydrogen or lower alkyl R.sub.1 is alkyl or aryl, aralkyl or aralkenyl radical, the aryl moiety of which can be substituted one or more times by halogen, hydroxyl, trifluoromethyl or lower alkyl, alkoxy or acyl R.sub.2 and R.sub.3 are individually selected from hydrogen or lower alkyl, and n is 0, 1, 2 or 3 and the physiologically acceptable salts, esters and amides thereof; are outstandingly effective in inhibiting thrombocyte aggregation.

  该公式中的Phenoxyalkylcarboxylic酸化合物，其中R是氢或较低的烷基，R.sub.1是烷基或芳基，芳基可以被卤素、羟基、三氟甲基或较低的烷基、烷氧基或酰基取代一次或多次，R.sub.2和R.sub.3分别选自氢或较低的烷基，n为0、1、2或3，其生理上可接受的盐、酯和酰胺在抑制血小板聚集方面具有出色的效果。
• C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
  申请人：——

  公开号：US20020028774A1

  公开（公告）日：2002-03-07

  This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

  这项发明涉及新颖的oxamyl二肽ICE/ced-3家族抑制剂化合物。该发明还涉及含有这些化合物的药物组合物，以及将这些组合物用于治疗患有炎症、自身免疫和神经退行性疾病的患者，预防缺血性损伤，并保护将要进行移植手术的器官。